| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AN2 Therapeutics, Inc. | Chief Operating Officer and Chief Legal Officer | Common Stock | 177K | $202K | $1.14 | 04 Nov 2025 | Direct |
| AN2 Therapeutics, Inc. | Chief Operating Officer and Chief Legal Officer | Stock Option (right to buy) | 117K | 26 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | 04 Nov 2025 | 1 | -$3.21K | 4 | Chief Operating Officer and Chief Legal Officer | 06 Nov 2025, 18:12 |
| ANTX | AN2 Therapeutics, Inc. | 26 Feb 2025 | 2 | $0 | 4 | Chief Operating Officer and Chief Legal Officer | 28 Feb 2025, 16:22 |
| ANTX | AN2 Therapeutics, Inc. | 03 Jan 2025 | 1 | -$13K | 4 | Chief Operating Officer and Chief Legal Officer | 07 Jan 2025, 19:57 |
| ANTX | AN2 Therapeutics, Inc. | 04 Nov 2024 | 2 | $0 | 4 | Chief Operating Officer and Chief Legal Officer | 05 Nov 2024, 16:51 |
| ANTX | AN2 Therapeutics, Inc. | 10 Jul 2024 | 1 | $0 | 4 | Chief Legal Officer | 12 Jul 2024, 16:13 |
| ANTX | AN2 Therapeutics, Inc. | 15 Mar 2024 | 1 | $0 | 4/A | Chief Legal Officer | 29 Mar 2024, 16:18 |
| ANTX | AN2 Therapeutics, Inc. | 15 Mar 2024 | 2 | $0 | 4 | Chief Legal Officer | 18 Mar 2024, 19:28 |
| ANTX | AN2 Therapeutics, Inc. | 15 Feb 2023 | 1 | $0 | 4 | Chief Legal Officer | 17 Feb 2023, 18:24 |
| ANTX | AN2 Therapeutics, Inc. | 14 Oct 2022 | 1 | $0 | 4 | Chief Legal Officer | 28 Oct 2022, 18:03 |
| ANTX | AN2 Therapeutics, Inc. | 29 Sep 2022 | 0 | $0 | 3 | General Counsel, Chief Legal Officer and Corporate Secretary Exhibit 24 - Power of Attorney | 05 Oct 2022, 18:21 |